Sandbox:Hannan: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
Line 89: | Line 89: | ||
* MPAL, B/myeloid, NOS | * MPAL, B/myeloid, NOS | ||
* MPAL, T/myeloid, NO | * MPAL, T/myeloid, NO | ||
| | |||
| | |||
| | |||
|- | |||
|B-lymphoblastic leukemia/lymphoma | |||
* B-lymphoblastic leukemia/lymphoma, NOS | |||
* B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities | |||
* B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1 | |||
* B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged | |||
* B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1);ETV6-RUNX1 | |||
* B-lymphoblastic leukemia/lymphoma with hyperdiploidy | |||
* B-lymphoblastic leukemia/lymphoma with hypodiploidy | |||
* B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH | |||
* B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1 | |||
* Provisional entity: B-lymphoblastic leukemia/lymphoma, BCR-ABL1–like | |||
* Provisional entity: B-lymphoblastic leukemia/lymphoma with iAMP | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | | | ||
| | | |
Revision as of 12:35, 15 January 2019
Other myeloid neoplasm and acute leukemia | |||
---|---|---|---|
Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of
PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2
|
|||
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
|
|||
Myelodysplastic syndromes (MDS)
|
|||
Acute myeloid leukemia (AML) and related neoplasms
|
|||
Blastic plasmacytoid dendritic cell neoplasm | |||
Acute leukemias of ambiguous lineage
|
|||
B-lymphoblastic leukemia/lymphoma
|
|||
(CML), BCR-ABL1+
- prefibrotic/early stage
- overt fibrotic stage